Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 3251
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
68733
Very happy that only the basic information needed
(6)
petemantx
02/26/2021 10:00:34 AM
68731
They don't want to say that they are going to
(8)
Drano
02/26/2021 9:47:11 AM
68730
Anyone have thoughts on the line about
(1)
Shry
02/26/2021 9:45:03 AM
68728
PR on a Friday, I hope Leo caught some shorts
(1)
pizza
02/26/2021 9:25:46 AM
68727
PR Today: Innovation Pharma Provides Study
(4)
gchgch
02/26/2021 9:11:03 AM
68722
Mo......great well written post! Thanks for
(2)
falcon74
02/25/2021 10:05:29 PM
68721
The New York variant of the virus may not be
(9)
Drano
02/25/2021 8:27:43 PM
68719
I mostly agree with your statement about criminal
(22)
Mo
02/25/2021 3:41:13 PM
68718
Existing indications repurposed to battle
(5)
crashco
02/25/2021 2:44:24 PM
68715
GSK Phase 2 Otilimab fails to meet Primary end
crashco
02/25/2021 2:33:35 PM
68713
Hi Jim, the User who authored that post is
BooDog
02/25/2021 11:10:50 AM
68712
admins over there must be making bank deleting
(1)
BooDog
02/25/2021 10:51:17 AM
68709
Here is a post by JFM on IFUD this morning that
(11)
falcon74
02/24/2021 5:11:33 PM
68707
I don't think uplisting is what will cut down on
(8)
petemantx
02/24/2021 3:56:18 PM
68706
I cant wait until we up-list. The manipulation
(4)
stocker11
02/24/2021 3:48:07 PM
68705
Remember that some time ago it was mentioned
(3)
Drano
02/24/2021 11:49:25 AM
68704
That is good to know as it seems it has taken
(2)
petemantx
02/24/2021 11:21:14 AM
68703
Agree , only posted that link to show what other
NotRichYet2
02/24/2021 9:57:07 AM
68702
Unlike the vaccines that require a specialized
(8)
Drano
02/24/2021 9:37:46 AM
68701
Kind of like predicting a car's time at the drag
(5)
petemantx
02/24/2021 9:35:44 AM
68700
Makes me also wonder if the foreign part of the
(3)
petemantx
02/24/2021 9:22:42 AM
68698
Here is a computerized ANALISIS of IPIX's
(1)
NotRichYet2
02/24/2021 8:27:13 AM
68696
Why is the phII trial not on clinicaltrials . gov
kerdom
02/24/2021 8:14:44 AM
68695
Awesome post Mo! I see it playing out pretty much
(5)
Ultimate
02/24/2021 7:31:35 AM
68693
My opinion on the number of B-CV19 trials is as
(20)
Mo
02/24/2021 1:11:57 AM
68692
I agree that Leo has missed a few PR
(1)
thefamilyman
02/24/2021 12:57:59 AM
68691
Leo put out quite a few PRs last year. Many some
(2)
Commando911
02/23/2021 11:47:56 PM
68690
Thank-you Pete, as usual a killer
angeli
02/23/2021 10:47:57 PM
68688
My take on "the market" is that retail are pawns
(11)
petemantx
02/23/2021 7:10:01 PM
68686
Speculation: I am also intrigued by the word
(4)
doubleJ23
02/23/2021 1:23:51 PM
68685
Ive been checking that site regularly.
Patchesohoulihan
02/23/2021 11:21:13 AM
68682
"it wont be long before we hear something."
(7)
farrell
02/23/2021 10:54:06 AM
68681
Don't get all hung up trying to parse language.
(4)
Drano
02/23/2021 10:23:05 AM
68680
Like I mentioned before, I also want additional
(6)
Ultimate
02/23/2021 10:10:32 AM
68678
Hi all, I'm trying to do some DD and see if there
(2)
doubleJ23
02/23/2021 9:46:24 AM
68675
A good and respected friend sent me this note
(10)
petemantx
02/22/2021 8:19:20 PM
68674
My take on todays events and 10-Q filing is
(13)
Mo
02/22/2021 5:47:17 PM
68673
I think the FDA is going to be trying very hard
(5)
Drano
02/22/2021 4:42:33 PM
68672
Just saw Fauci giving an update with a lot of
(4)
Chemdeps
02/22/2021 4:03:31 PM
68671
With the amount of people needed to fill the 120
(2)
petemantx
02/22/2021 3:56:07 PM
68670
Thats exactly as I see it. We are out of 1st
(2)
Ultimate
02/22/2021 3:00:50 PM
68669
Last week there was a document that showed 17, so
Drano
02/22/2021 2:48:13 PM
68668
Drano......I agree that common sense would tell
(1)
falcon74
02/22/2021 2:10:23 PM
68667
There are 17 clinical trial sites in Russia. I
(1)
Drano
02/22/2021 1:38:59 PM
68666
Chem---- I completely agree with your
(5)
falcon74
02/22/2021 1:04:10 PM
68665
I thought the statement that the phase II trials
(3)
Chemdeps
02/22/2021 12:52:08 PM
68664
Pete From the AS agreement. (i) Development
(3)
bettingbig
02/22/2021 12:18:54 PM
68663
Here's a list of "highlights" from the 10Q that I
(6)
Drano
02/22/2021 12:02:10 PM
68661
Is a successful P1 by AS considered a milestone
(1)
petemantx
02/22/2021 11:50:58 AM
68659
A little something MORE to look forward to.
(4)
NotRichYet2
02/22/2021 11:45:20 AM
Newer
Older
Recent Articles
Lyno AI Revolutionizes Investment with Successful Token Presale
Ålandsbanken Abp Initiates an Important Noteholder Procedure
Industry Insights: Ross Gerber Weighs in on Waymo's Advancements
Investors Seek to Lead Class Action Against Semler Scientific
Nutex Health Investors Encouraged to Join Fraud Due Diligence
Investors Encouraged to Join PubMatic Class Action Lawsuit
Investors Take Action: KinderCare Learning Faces Legal Battle
Securities Litigation Against Flywire Corporation: Know Your Rights
RxSight, Inc. Investors Alerted on Possible Securities Violations
Gimme Credit Welcomes New Analysts to Enhance High Yield Services
Gimme Credit Strengthens Global Bond Research Team
Milesight and Vemco Join Forces for Innovative Space Solutions
Join the Lineage, Inc. Securities Investigation Opportunity
Fusion Homes Advances Vision for Guelph Innovation District
Forecasting the Rapid Growth of the Hardware Acceleration Market
Apple's Innovative Foldable iPhone Production Plans Unveiled
Bullish Shares Surge After Positive Earnings Report
Coty Inc's Ongoing Investigation Brings Hope for Investors
Potential Legal Scrutiny for aTyr Pharma: Seeking Justice for Investors
Discover the Wonders of Mleiha National Park in the UAE
Trump's Bold Stance on Kimmel's Show Cancellation and Media Influence
Understanding the Effects of Fed Rate Cuts on Your Finances
Telenor Sweden and Mycom Enhance 5G Experience with Renewal
AtlasClear Holdings Rises 15% After Successful Financing Round
Sungrow Partners with EP Produzione for Major Battery Project
Rubenstein Law Achieves Significant Win in Slip and Fall Case
Exploring China’s Expanding Economic Footprint in Africa
Google Workspace: The Leading AI Assistant for Productivity
Payentry Partners with Equifax for Enhanced Employment Verification
MEDIPEEL's Europe Expansion Strategy Boosts Global Presence
Telenor Sweden and Mycom Strengthen Partnership for 5G Success
PotisEdge Introduces Innovative Energy Storage Solutions
Courageous Canadian Pilots Provide Hope Amidst Conflict
AXIL Brands Expands Reviv3 Procare Product Line with Chatters
InterDigital Welcomes Julia C. Mattis as New Chief Licensing Officer
Norðurþing Reports 2025 Financial Performance Overview
Sompo International Welcomes Alessandrea Quane as New CEO
Novo Nordisk Reveals Ozempic® Breakthrough Study Results
Investors Eye S&P 500 Gains as Fed Cuts Rates and Recession Feared
iHuman Inc. Shares Q2 2025 Financial Performance Insights
Upcoming Earnings: Key Financial Insights for Investors
Investors Seek Justice Against Fly-E Group for Securities Fraud
Savara Inc. Faces Class Action Over Alleged Securities Fraud
Legal Opportunities Emerges for SelectQuote, Inc. Investors
Digital Intelligence Era Boosts International Arbitration Initiatives
Investors Urged to Join KBR, Inc. Fraud Investigation Today
Rapidtek Unveils FoldSAT Portable LEO Terminal for Future Use
Alessandrea Quane Takes the Helm as CEO of Sompo's International Markets
Julia C. Mattis Takes Charge as Chief Licensing Officer at InterDigital
Investors Alert: Investigating Sable Offshore Corp. Securities Issues